Mendor, a leading diabetes technology company from Espoo Finland, has announced to have completed a new series of growth financing during 2013 for global expansion totaling 4,7 million euros. The round came from existing and new investors from Finland and abroad.
Mendor is a fast growing diabetes technology company, committed to the design, development and commercialization of next generation diabetes care products. Mendor’s vision is a future where diabetes care is integrated, individual and outcome driven.
Source: www.mendor.com
